Jump to content

A Platform Approach to Manage Developability and Manufacturability Risks of Biologics

PEGS Europe, Lisbon, Portugal
November 21, 2019

The Genedata Biopharma Platform offers sophisticated solutions for the discovery process, for bioprocess development, and for the characterization of biopharmaceuticals. A platform approach to developability and manufacturability strategies enables information gained at all stages of research and development to be stored in a highly structured database. Theoretical and experimental data from various assay types — including any plate-, mass spectrometry-and NGS-based assays — is leveraged to ensure technical success for chosen lead molecules.

Request Resource

By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Genedata privacy policy